- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- ASCs’ vendor problem
- Providence’s physician chief on its ‘holistic’ approach to value-based care
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Anesthesia job market faces ‘major disruption’
- Florida system raises $100M for new ED
- North Carolina system names COO
- Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally
- UCI Health names chief AI officer
- Nevada hospital names CEO
- Saint Luke’s taps president for 2 hospitals
- Dental community mourns dentist killed in murder-suicide
- Mass General Brigham, CVS deal could raise healthcare spending $40M annually: Report
- Ideal Dental opens 1st Oklahoma practice, expands in 2 more states
- PDS Health eyes the next era of medical-dental integration
- Mark Cuban dives into direct contracting
- HCA executive pay by the numbers
- Iris Telehealth offers behavioral health analytics platform
- HHS names chief economist, regulatory leader to address healthcare affordability
- Loma Linda University Health names new president
- The best ASCs for colonoscopy, endoscopy in the South: US News
- Tennessee moves forward with CON repeal
- Dental schools take action to alleviate workforce shortages: 6 updates
- American Medical Group Association partners with Talkiatry to expand psych access
- Trump nominates CDC director
- ChristianaCare, Cardiovascular Physicians of Delaware to open joint venture ASC
- 5 states regulating AI in mental health
- Centerstone debuts $13M youth behavioral health campus in Missouri
- 3 DSOs making headlines
- Maine restricts noncompetes for rural healthcare workers
- Heartland Dental opens Florida office
- The 10 biggest ASC deals of the last 5 years
- Affordability, transparency: A look at large employers' top healthcare concerns
- 10 dental Medicaid updates to know from Q1
- White House eyes ibogaine research expansion
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The future of medical-dental integration is here
- Texas dentist has license suspended
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- What’s the deal with insurer mental health parity violations?
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- EPA Delays Decisions on 'Forever Chemicals'
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Progyny unveils new fertility benefit option for small, mid-size employers
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- Hospitals with more disadvantaged patients fall short on price transparency, study finds
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Does Your Child Have Nightmares? Here's One Solution
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
Scott W. Atlas, M.D., is the Robert Wesson Senior Fellow in health care policy at the Hoover Institution of Stanford University and a fellow at Hillsdale College's Academy for Science and Freedom. From July to December 2020, he served as a Special Advisor to the President and a member of the White House Coronavirus Task Force. He was savaged by the COVID Nazis, but he was one of the few public health 'experts' free from the corrupting influence of Big Pharma and a steady hand in the storm:
Today’s Public Health Emergency: Restoring Trust With Seven Steps
October 30, 2023
The public health emergency of the SARS2-CoV pandemic ended long ago, but America faces a new emergency. Faith in health agencies has plummeted more rapidly since 2019 than any other government institution, with almost two-thirds now rating the FDA and the CDC as “only fair or poor.” Half of America no longer has much confidence in science itself.The loss of trust is part of the disgraceful legacy of those who held power during the pandemic. Two presidents and dozens of governors hid behind public health bureaucrats Anthony Fauci, Deborah Birx, Robert Redfield, and Rochelle Walensky. They ignored Henderson’s classic review 15 years earlier showing lockdowns were both ineffective and extremely harmful. They rejected the alternative, targeted protection, recommended as early as March 2020 by Ioannidis, Katz, and Atlas. Beyond a reckless disregard for foreseeable destruction from their policies, America’s leaders imposed sinful harms and long-lasting damage on our children, the totality of which may not be realized for decades. Mandatory school closings, forced isolation of teens and college students, and required injections of healthy children with experimental drugs attempting to shield adults will be a permanent black mark on America. And the truth cannot be denied – the Birx-Fauci lockdowns failed to stop the death and the spread of infection (see Bjornskov, Bendavid, Agrawal, Herby, and Kerpen) and inflicted tremendous harms, shifting the pandemic burden to low-income families to spare the affluent.
America’s next president needs to lead with strong reforms, because the Birx-Fauci stain on public health and science jeopardizes the credibility of all future health guidance. Here are some recommended initial executive orders:
- Clearly define by law “public health emergency” with strict time limits (e.g., two weeks), requiring legislation to extend. Human rights were violated in the United States. Guarantees of the most fundamental freedoms upon which this country was founded – speech, religion, assembly – were suddenly reversed, without limit, by lockdowners under the guise of “the science” and “safety.” The U.S., with freedoms explicitly defined as “endowed by their Creator,” must be managed in concert with its system of laws, even during health emergencies.
- Add term limits (e.g., six years) to all health agency positions, including top- and mid-level posts, after first cleaning house of all heads of CDC, NIH, and FDA. For instance, Anthony Fauci worked as a bureaucrat for 38 years. Such longevity accrues power and seems to inhibit dissenting voices, while setting up unhealthy relationships with outside parties, including the media.
- Forbid all drug royalty-sharing by employees of FDA, NIH, CDC, and forbid related private jobs for five years after government service. OpenTheBooks revealed that between 2009 and 2021, approximately 54,000 royalty payments totaling $325.8 million were paid by third party entities to NIH researchers, sources redacted. We know that Dr. Francis Collins, the NIH’s former director, received 21 payments and Dr. Anthony Fauci received 37 payments between 2010 and 2021. This shocking conflict of interest, with hundreds of agency employees garnering personal profit forcibly revealed by FOIA requests, is the most urgent among many reforms.
- Require full transparency of all FDA, CDC, and NIH discussions with immediate posting to public forums. Statements from all advisors in those meetings, such as the startling October 26, 2021, recommendation of Eric Rubin, M.D., FDA advisor for children’s COVID vaccines, that “we’re never going to learn about how safe this vaccine is [in children] unless we start giving it. That’s just the way it goes,” must be widely visible to the public.
- Restatement with executive order that the CDC and other health agencies are strictly advisory and do not have power to set laws or mandates. Limiting health agency power is a way to begin holding elected officials accountable to the citizens, rather than allowing the pretense of hiding behind those agencies.
- Decentralize today’s cartel of NIH funding that controls all academic science careers and university medical centers. More than 15 U.S. medical centers receive over $500 million each – per year – from the NIH, the dominant funder of all scientific research, to the tune of $45 billion per year. Leverage on individual university scientists who owe their careers to NIH funding explains the February 2020 Lancet publication concocted behind closed doors calling the lab origin of the SARS2 virus a “conspiracy theory”– perhaps to conceal NIH malfeasance overseen by Drs. Collins and Fauci, who sent more than $2 million taxpayer dollars to fund China’s dangerous gain-of-function research to circumvent our country’s restrictions. Instead, disseminating control of NIH funding across regions with block grants to states would reduce this grip on independent voices.
- Immediately halt all binding agreements or pledges to the World Health Organization. The U.S. is the largest funding nation to WHO activities, but the WHO record is abysmal. In addition to supporting China’s stonewalling, Director Tedros backed China’s reckless human rights violations, stating “the Chinese government is to be congratulated for the extraordinary measures it has taken to contain the outbreak,” even as it used pseudoscience to essentially imprison its citizens. WHO disregarded evidence in its guidelines on mitigation, censored its own staff for acknowledging limits of asymptomatic spread, and flipped fundamental definitions like “herd immunity“ to influence behavior, rather than to dispassionately inform with data. We must hope Tedros was joking when he said, “China is actually setting a new standard for outbreak response.” Blind to the obvious need for reassessment, the Biden administration’s ambassador to the WHO Pamela Hamamoto already promised “The United States is committed to the [WHO’s] Pandemic Accord” even without seeing the final version. In that Accord, the WHO will define “public health emergency” for other countries – the fundamental basis to justify restrictions on the public. What is the rationale for any sovereign nation to allow a third party to legally define and impose such a critical state?
Finally, American voters need to wake up and hold elected officials accountable. Without substantial reforms, the promised freedoms of the United States will have lost legitimacy.
In my view, public health is the backwater of US healthcare.
The need it met before the information age has long expired. Now, public health officials are simply desperate to prove they're still needed - usually for a progressive political agenda.
Limiting public health power is a great first step. Because funding = power, step one should be followed closely by massive reductions in spending.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














